A new series of the SMTP plasminogen modulators with a phenylamine-based side chain

Journal of Antibiotics

Volumn 65, Issue 7, 2012, Pages 361-367

  Koide, Haruki ^a   Hasegawa, Keiko ^b   Nishimura, Naoko ^b   Narasaki, Ritsuko ^a   Hasumi, Keiji ^a,b  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b Division of Research and Development   (Japan)

Author keywords

fibrinolysis; plasminogen modulator; proteolysis; radical scavenger; structure activity relationships

Indexed keywords

2 HYDROXYPHENYL 3 CARBOXYLIC ACID; 3 HYDROXYPHENYL 4 CARBOXYLIC ACID; 4 PHENYLCARBOXYLIC ACID; ANILINE; CARBOXYLIC ACID DERIVATIVE; HYDROXYL GROUP; OXYGEN RADICAL; PLASMINOGEN ACTIVATOR; SMTP 18; SMTP 19; SMTP 20; SMTP 21; SMTP 22; SMTP 23; SMTP 24; SMTP 25; SMTP 26; SMTP 27; SMTP 28; SMTP 7; STACHYBOTRYS MICROSPORA TRIPRENYL PHENOL; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOMER; NONHUMAN; PHYSICAL CHEMISTRY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL;

ANILINE COMPOUNDS; BENZOPYRANS; FREE RADICAL SCAVENGERS; HUMANS; PLASMINOGEN ACTIVATORS; PYRROLIDINONES; STACHYBOTRYS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84864472768     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2012.29     Document Type: Article

References (26)

1. Rijken, D. C. amp; Lijnen, H. R. New insights into the molecular mechanisms of the fibrinolytic system. J. Thromb. Haemost. 7, 4-13 (2008).
2. Castellino, F. J. amp; Ploplis, V. A. Structure and function of the plasminogen/plasmin system. Thromb. Haemost. 93, 647-654 (2005).
3. Cockell, C. S Marshall, J. M Dawson, K. M Cederholm-Williams, S. A. amp; Ponting, C. P. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. Biochem. J. 333, 99-105 (1998).
4. An, S. S. et al. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles. Protein Sci. 7, 1960-1969 (1998).
5. Hasumi, K Yamamichi, S. amp; Harada, T. Small molecule modulators of the zymogen activation in the fibrinolytic and coagulation systems. FEBS J. 277, 3675-3687 (2010).
6. Takayasu, R Hasumi, K Shinohara, C. amp; Endo, A. Enhancement of fibrin binding and activation of plasminogen by staplabin through induction of a conformational change in plasminogen. FEBS Lett. 418, 58-62 (1997).
7. Ohyama, S Harada, T Chikanishi, T Miura, Y. amp; Hasumi, K. Nonlysine-analog plasminogen modulators promote autocatalytic generation of plasmin(ogen) fragments with angiostatin-like activity. Eur. J. Biochem. 271, 809-820 (2004).
8. Hashimoto, T Shibata, K Nobe, K Hasumi, K. amp; Honda, K. A novel embolic model of cerebral infarction and evaluation of SMTP-7, a novel fungal triprenyl phenol metabolite. J. Pharmacol. Sci. 114, 41-49 (2010).
9. Shibata, K Hashimoto, T Nobe, K Hasumi, K. Honda, K. A novel finding of a lowmolecular-weight compound, SMTP-7, having thrombolytic and anti-inflammatory effects in cerebral infarction of mice. Naunyn Schmiedebergs Arch. Pharmacol. 382, 245-253 (2010).
10. Miyazaki, T. et al. Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion. Stroke 42, 1097-1104 (2011).
11. Shibata, K Hashimoto, T Nobe, K Hasumi, K. Honda, K. Neuroprotective mechanisms of SMTP-7 in cerebral infarction model in mice. Naunyn Schmiedebergs Arch. Pharmacol. 384, 103-108 (2011).
12. Akamatsu, Y. et al. Stachybotrys microspora triprenyl phenol-7, a novel fibrinolytic agent, suppresses superoxide production, matrix metalloproteinase-9 expression, and thereby attenuates ischemia/reperfusion injury in rat brain. Neuroscience Lett. 503, 110-114 (2011).
13. Shinohara, C Hasumi, K Hatsumi, W. Endo, A. Staplabin, a novel fungal triprenyl phenol which stimulates the binding of plasminogen to fibrin and U937 cells. J. Antibiot. 49, 961-966 (1996).
14. Kohyama, T Hasumi, K Hamanaka, A. Endo, A. SMTP-1 and -2, novel analogs of staplabin produced by Stachybotrys microspora IFO30018. J. Antibiot. 50, 172-174 (1997).
15. Hasumi, K. et al. Isolation of SMTP-3, -4, -5 and -6, novel analogs of staplabin, and their effects on plasminogen activation and fibrinolysis. J. Antibiot. 51, 1059-1068 (1998).
16. Hu, W Ohyama, S. Hasumi, K. Activation of fibrinolysis by SMTP-7 and -8, novel staplabin analogs with a pseudosymmetric structure. J. Antibiot. 53, 241-247 (2000).
17. Hu, W Kitano, Y. Hasumi, K. SMTP-4D, -5D, -6D, -7D and -8D, a new series of the non-lysine-analog plasminogen modulators with a D-amino acid moiety. J. Antibiot. 56, 832-837 (2003).
18. Hasumi, K Hasegawa, K. Kitano, Y. Isolation and absolute configuration of SMTP-0, a simplest congener of the SMTP family nonlysine-analog plasminogen modulators. J. Antibiot. 60, 463-468 (2007).
19. Hasegawa, K. et al. Structure-activity relationships of fourteen new congeners of the SMTP plasminogen modulator. J. Antibiot. 63, 589-593 (2010).
20. Koide, H Narasaki, R Hasegawa, K Nishimura, N. Hasumi, K. A new series of the SMTP plasminogen modulator with a phenylglycine-based side-chain. J. Antibiot. 65, 91-93 (2012).
21. Hasumi, K. et al. (Tokyo University of Agriculture and Technology TLO Co Ltd.). Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer. PCT/JP2007/055749, March 20 (2007).
22. Hasumi, K Ishikawa, M Chikanishi, T Nishimura, N. Hasegawa, K. (Tokyo University of Agriculture and Technology). Pharmacological composition for metabolic syndrome, obesity, hyperglycemia, hyperlipidemia and/or fatty liver. PCT/JP2010/ 053545, March 4 (2010).
23. Honda, K Hashimoto, T Shibata, K Hasegawa, K. Hasumi, K. (Tokyo University of Agriculture and Technology; Showa University; TMS Co Ltd.). Cytoprotective agent. PCT/JP2010/051711, February 5 (2010).
24. Ishikawa, M Tanaka, I Shirafuji, T. Hasumi, K. (Nihon Pharmaceutical Co Ltd. and TMS Co Ltd.). Prophylactic or therapeutic agent for inflammatory bowel diseases or autoimmune peripheral neuropathy. PCT/JP2011/058405, April 1 (2011).
25. Hu, W Ohyama, S Narasaki, R. Hasumi, K. Selective production of staplabin and SMTPs in cultures of Stachybotrys microspora fed with precursor amines. J. Antibiot. 54, 962-966 (2001).
26. Wu, X. et al. Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J. Agric. Food Chem. 52, 4026-4037 (2004).